New immunosuppressive agents in pediatric transplantation

被引：13
作者：
Christina Nguyen [1 ]
Shapiro, Ron [2 ]
机构：
[1] UPMC, Childrens Hosp Pittsburgh, Div Pediat Nephrol, Pittsburgh, PA 15219 USA
[2] UPMC, Thomas E Starzl Transplantat Inst, Div Transplant Surg, Pittsburgh, PA USA
来源：
CLINICS | 2014年 / 69卷
关键词：
Transplantation; Pediatric Transplantation; Immunosuppression; DOSE CYCLOSPORINE MONOTHERAPY; HEMOLYTIC-UREMIC SYNDROME; IMPROVED RENAL-FUNCTION; MYCOPHENOLATE-MOFETIL; CALCINEURIN INHIBITOR; LIVER-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; MULTICENTER TRIAL; RANDOMIZED-TRIAL; CAMPATH; 1H;
D O I：
10.6061/clinics/2014(Sup01)03
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Immunosuppressive therapy in pediatrics continues to evolve. Over the past decade, newer immunosuppressive agents have been introduced into adult and pediatric transplant patients with the goal of improving patient and allograft survival. Unfortunately, large-scale randomized clinical trials are not commonly performed in children. The purpose of this review is to discuss the newer immunosuppressive agents available for induction therapy, maintenance immunosuppression, and the treatment of rejection.
引用
收藏
页码：8 / 16
页数：9
相关论文
共 73 条
[41]   Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation [J].
Mjornstedt, L. ;
Sorensen, S. S. ;
von zur Muhlen, B. ;
Jespersen, B. ;
Hansen, J. M. ;
Bistrup, C. ;
Andersson, H. ;
Gustafsson, B. ;
Undset, L. H. ;
Fagertun, H. ;
Solbu, D. ;
Holdaas, H. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (10) :2744-2753
[42]   Rapid Reduction in Donor-Specific Anti-Human Leukocyte Antigen Antibodies and Reversal of Antibody-Mediated Rejection With Bortezomib in Pediatric Heart Transplant Patients [J].
Morrow, William Robert ;
Frazier, Elizabeth A. ;
Mahle, William T. ;
Harville, Terry O. ;
Pye, Sherry E. ;
Knecht, Kenneth R. ;
Howard, Emily L. ;
Smith, R. Neal ;
Saylors, Robert L. ;
Garcia, Xiomara ;
Jaquiss, Robert D. B. ;
Woodle, E. Steve .
TRANSPLANTATION, 2012, 93 (03) :319-324
[43]  
Moudgil Asha, 2007, Paediatr Drugs, V9, P323
[44]   A Comprehensive Review of Immunosuppression Used for Liver Transplantation [J].
Mukherjee, Sandeep ;
Mukherjee, Urmila .
JOURNAL OF TRANSPLANTATION, 2009, 2009
[45]   Pre-emptive Eculizumab and Plasmapheresis for Renal Transplant in Atypical Hemolytic Uremic Syndrome [J].
Nester, Carla ;
Stewart, Zoe ;
Myers, David ;
Jetton, Jennifer ;
Nair, Ramesh ;
Reed, Alan ;
Thomas, Christie ;
Smith, Richard ;
Brophy, Patrick .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06) :1488-1494
[46]   Eculizumab for Atypical Hemolytic-Uremic Syndrome. [J].
Nuernberger, Jens ;
Witzke, Oliver ;
Saez, Anabelle Opazo ;
Vester, Udo ;
Baba, Hideo Andreas ;
Kribben, Andreas ;
Zimmerhackl, Lothar Bernd ;
Janecke, Andreas R. ;
Nagel, Mato ;
Kirschfink, Michael .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05) :542-544
[47]   Chronic renal failure after transplantation of a nonrenal organ [J].
Ojo, AO ;
Held, PJ ;
Port, FK ;
Wolfe, RA ;
Leichtman, AB ;
Young, EW ;
Arndorfer, J ;
Christensen, L ;
Merion, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10) :931-940
[48]   Long-Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates [J].
Oura, T. ;
Yamashita, K. ;
Suzuki, T. ;
Fukumori, D. ;
Watanabe, M. ;
Hirokata, G. ;
Wakayama, K. ;
Taniguchi, M. ;
Shimamura, T. ;
Miura, T. ;
Okimura, K. ;
Maeta, K. ;
Haga, H. ;
Kubota, K. ;
Shimizu, A. ;
Sakai, F. ;
Furukawa, H. ;
Todo, S. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (07) :1740-1754
[49]   First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses [J].
Painter, Wendy ;
Robertson, Alice ;
Trost, Lawrence C. ;
Godkin, Susan ;
Lampert, Bernhard ;
Painter, George .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) :2726-2734
[50]  
Paoletti E, 2009, Transplant Proc, V41, pS3, DOI 10.1016/j.transproceed.2009.06.091
12345678